BlackRock Japan’s Global Blood Therapeutics, Inc. GBT Stock Holding History

BlackRock Japan’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$0	Buy	+26	New	+$457	﹤0.01%	1397

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock Japan's GBT Position: Q4 2016 in Review

BlackRock Japan opened a new position in Global Blood Therapeutics, Inc. (GBT) in Q4 2016: 26 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1397 among its holdings.

96 funds tracked by Wall St. Rank hold GBT as of Q4 2016.

BlackRock Japan held 26 shares of Global Blood Therapeutics, Inc. worth $0 as of Q4 2016.
Global Blood Therapeutics, Inc. was a new BlackRock Japan position in Q4 2016.
Global Blood Therapeutics, Inc. made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1397 holding.
96 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.